Ambu AuraGain versus Intubating Laryngeal Mask Airway (Fastrach) as Conduits for Blind Intubation – A Prospective Randomized Study
No Thumbnail Available
Date
2023-06
Journal Title
Journal ISSN
Volume Title
Publisher
International Research Organization for Life & Health Sciences
Abstract
Introduction: The original laryngeal mask airway (LMA) was the first supraglottic airway introduced into clinical practice and wasinvented by DR. Archie Brain in 1981. There have been several modifications to the LMA over the years – camera attachments,conduits for endotracheal intubation, gastric channel, and so on. The present study was done to compare the efficacy of newsecond-generation SGA Ambu®AuraGain (AAG) and Intubating LMA as conduits for blind intubation.Materials and Methods: This prospective study was carried out in the “Department of Anesthesiology, Government MedicalCollege, Amritsar,” on 60 patients in the age group of 18–60 years of either sex and the American Society of AnesthesiologistsGrade I and II. The patients were randomly divided into two groups of 30 each and were comparable in terms of age, sex, duration,and nature of the procedure they underwent. The two groups were comparable in demographic data and patient characteristics.Results: The successful intubation rate through FT-LMA and AG-LMA was 96.66% and 33.33%, respectively. The differencein the overall success rate of intubation between both groups was highly significant with P < 0.05.Conclusion: Fastrach LMA has a higher success rate of intubation than AAG
Description
Keywords
Airway management, Ambu AuraGain, Fastrach LMA, Intubation
Citation
Arora HS, Mohan B, Badhan A, Kaur H. Ambu AuraGain versus Intubating Laryngeal Mask Airway (Fastrach) as Conduits for Blind Intubation – A Prospective Randomized Study. International Journal of Scientific Study. 2023 Jun; 11(3): 52-57